Clinical Trial: Sugammadex-Induced Clenching During Neuromuscular Blockade Reversal
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Neuromuscular Blockade Reversal Agent
Study Type: INTERVENTIONAL
Official Title: A Prospective, Randomized, Double-Blind Study of the Incidence, Severity, and Risk Factors of Clenching Induced by Sugammadex During Neuromuscular Blockade Reversal
Brief Summary:
Study Objective:This study aims to evaluate the incidence, severity, and risk factors of sugammadex-induced mouth clenching during neuromuscular blockade (NMB) reversal in adult surgical patients.Study Design:This prospective, randomized, double-blind, controlled clinical trial enrolls adult patients (ASA physical status I-II, aged 19-70 years) undergoing elective surgery under general anesthesia with rocuronium.Patients will be randomized into four groups to receive either sugammadex at doses of 1 mg/kg, 2…
Read more